Moderna Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Business Updates – Moderna Investor Relations

  1. Moderna Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Business Updates  Moderna Investor Relations
  2. Moderna’s Results Reaffirm a Grim Picture for Vaccine Maker  Barron’s
  3. Moderna beats on revenue but loses more than expected as it scales down manufacturing  CNBC
  4. Moderna’s wider-than-expected loss and soft guidance weigh on battered stock  MarketWatch
  5. Moderna posts bigger loss than expected as vaccine maker scales down manufacturing  Reuters